Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

Showing results (131-140 of 306) with videos related to

Pageof 31
Sort By:
American Heart Journal|September 26, 2006
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)C Michael Gibson, Ajay J Kirtane, David A Morrow, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2017
Outcomes, readmissions, and costs in transfemoral and alterative access transcatheter aortic valve replacement in the US Medicare populationFenton H McCarthy, Danielle D Spragan, Danielle Savino, et al.
JACC. Cardiovascular Interventions|April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT TrialRim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2017
Cost and contribution margin of transcatheter versus surgical aortic valve replacementFenton H McCarthy, Danielle C Savino, Chase R Brown, et al.
The American Journal of Cardiology|April 13, 2015
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial)Brian P O'Neill, Mayra Guerrero, Vinod H Thourani, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Disparities in Utilization of Advanced Structural Heart Cardiovascular TherapiesAndrew M Goldsweig, Megan Coylewright, Ramesh Daggubati, et al.
The Annals of Thoracic Surgery|August 24, 2014
Aortic and mitral valve replacement versus transcatheter aortic valve replacement in propensity-matched patientsFenton H McCarthy, Nimesh D Desai, Howard C Herrmann, et al.
The New England Journal of Medicine|April 5, 2019
Procedural Volume and Outcomes for Transcatheter Aortic-Valve ReplacementSreekanth Vemulapalli, John D Carroll, Michael J Mack, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Prospective <i>CYP2C19</i> Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical TrialSony Tuteja, Henry Glick, William Matthai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 17, 2009
Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradientHoward C Herrmann, Saibal Kar, Robert Siegel, et al.
Pageof 31

Showing results (131-140 of 306) with videos related to

Sort By:
Pageof 31
American Heart Journal|September 26, 2006
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)C Michael Gibson, Ajay J Kirtane, David A Morrow, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2017
Outcomes, readmissions, and costs in transfemoral and alterative access transcatheter aortic valve replacement in the US Medicare populationFenton H McCarthy, Danielle D Spragan, Danielle Savino, et al.
JACC. Cardiovascular Interventions|April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT TrialRim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2017
Cost and contribution margin of transcatheter versus surgical aortic valve replacementFenton H McCarthy, Danielle C Savino, Chase R Brown, et al.
The American Journal of Cardiology|April 13, 2015
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial)Brian P O'Neill, Mayra Guerrero, Vinod H Thourani, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Disparities in Utilization of Advanced Structural Heart Cardiovascular TherapiesAndrew M Goldsweig, Megan Coylewright, Ramesh Daggubati, et al.
The Annals of Thoracic Surgery|August 24, 2014
Aortic and mitral valve replacement versus transcatheter aortic valve replacement in propensity-matched patientsFenton H McCarthy, Nimesh D Desai, Howard C Herrmann, et al.
The New England Journal of Medicine|April 5, 2019
Procedural Volume and Outcomes for Transcatheter Aortic-Valve ReplacementSreekanth Vemulapalli, John D Carroll, Michael J Mack, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Prospective <i>CYP2C19</i> Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical TrialSony Tuteja, Henry Glick, William Matthai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 17, 2009
Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradientHoward C Herrmann, Saibal Kar, Robert Siegel, et al.
Pageof 31